MEDA Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Stage IV Natural Killer/T-cell Lymphoma
Status:
Completed
Trial end date:
2020-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of methotrexate, etoposide,
pegaspargase and dexamethasone (MEDA) chemotherapy and autologous hematopoietic stem cell
transplantation (Auto-HSCT) in patients with stage IV extranodal natural killer/T-cell
lymphoma, nasal type.
Phase:
N/A
Details
Lead Sponsor:
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine